• Home
  • ProJect Pharmaceutics GmbH
6
Oct
2026
Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026
stand 10A65
Book a meeting

ProJect Pharmaceutics GmbH

  • Pilot freeze-dryer
  • Pilot batch (e.g. Tox batch) manufacturing
  • Cytotoxic safety laboratories
  • LC-MS next generation analytics services
  • Lyophilization in pre-filled syringes
  • Frozen vials (glimpse into a lyo cycle's progress)
About ProJect Pharmaceutics GmbH

ProJect Pharmaceutics is a leading European CRO specialized in formulation and process development for parenteral drug products (biologics, ADCs and novel moieties, cytotoxic drugs, nanoparticular drug delivery systems). The company was founded in 2010 and is managed by leading experts in protein formulation and pharmaceutical process development with 35+ years of experience.
We are experts in stabilizing injectable drugs in liquid and freeze-dried forms in vials, bulk ware or as high concentrated drugs in highly specialized devices such as prefilled syringe systems. We develop towards a manufacturable product and up-scalable processes - independent of any manufacturing site.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less

Meet us at

  • CPHI Milan 2026

    CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
    stand 10A65
  • Country/Region:
    Germany
  • Founded:
    2010
  • On CPHI since:
    2015
  • Employees:
    1 - 24
Company types
Contract Research Organisation (CRO)
Primary activities
Analytical Services
Biopharmaceutical
Contract Research Organisation
Contact info
Show contact info Hide contact info

Products from ProJect Pharmaceutics GmbH (2)

  • Formulation development for injectable drug products

    Product Formulation development for injectable drug products

    An algorithm and science-based high-throughput approach to identify quickly the "sweet spot" (formulational optimum) for intrinsic stability of a biologic molecule.
  • Lyophilization process development

    Product Lyophilization process development

    An algorithm- and deep-niche knowledge-based approach to come quickly (in only 5 development lyo cycles) to the final most efficient and robust lyophilization cycle tailored to the drug product, which then can easily be transferred to a CMO for GMP manufacturing.

ProJect Pharmaceutics GmbH Resources (1)

  • PJP capabilities in a nutshell

    Brochure PJP capabilities in a nutshell

    A glimpse of main services offered by ProJect Pharmaceutics. Projects span from full development projects to short single work package feasibility studies (e.g. proof of concept).We offer a fee-for-service business model, short lead times (2-4 weeks start-up time), and a high budget and timelines compliance.